Karuna Therapeutics’ NDA for KarXT accepted by USFDA
If approved, KarXT would represent the first new pharmacological approach to treating schizophrenia in several decades
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
NDA
Bayer wins US priority review of drug against metastatic prostate cancer
With this, the German drugmaker seeks to widen the use of the prostate cancer drug from an early disease stage to metastatic cases
Zydus receives DCGI approval for Oxemia to treat anaemia in CKD patients
OxemiaTM (Desidustat) is an oral tablet formulation which is the first-in-India alternative to injectable…
Zydus develops new treatment for patients suffering from Chronic Kidney Disease (CKD)
The company submits first New Drug Application (NDA) to DCGI
FDA approves Dr Reddy’s NDA for migraine drug
The company is working to commercialise Elyxyb (previously known as DFN-15), which is indicated for the acute treatment of…
Will NDA-2’s first budget be any different for the pharma sector?
With actual fiscal outcomes for FY19 falling short of the revenue estimates put out in the interim budget, FM Sitharaman will have…